Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats.

Johnson KW, Morin SM, Wroblewski VJ, Johnson MP.

Cephalalgia. 2019 Apr 19:333102419844711. doi: 10.1177/0333102419844711. [Epub ahead of print]

PMID:
31003588
2.

CGRP and the Trigeminal System in Migraine.

Iyengar S, Johnson KW, Ossipov MH, Aurora SK.

Headache. 2019 May;59(5):659-681. doi: 10.1111/head.13529. Epub 2019 Apr 14. Review.

PMID:
30982963
3.

How artificial intelligence could redefine clinical trials in cardiovascular medicine: lessons learned from oncology.

Krittanawong C, Johnson KW, Tang WW.

Per Med. 2019 Mar;16(2):83-88. doi: 10.2217/pme-2018-0130. Epub 2019 Mar 6. No abstract available.

PMID:
30838909
4.

Deep learning for cardiovascular medicine: a practical primer.

Krittanawong C, Johnson KW, Rosenson RS, Wang Z, Aydar M, Baber U, Min JK, Tang WHW, Halperin JL, Narayan SM.

Eur Heart J. 2019 Feb 27. pii: ehz056. doi: 10.1093/eurheartj/ehz056. [Epub ahead of print]

PMID:
30815669
5.

Differential Inhibition of Neuronal Sodium Channel Subtypes by the General Anesthetic Isoflurane.

Zhou C, Johnson KW, Herold KF, Hemmings HC Jr.

J Pharmacol Exp Ther. 2019 May;369(2):200-211. doi: 10.1124/jpet.118.254938. Epub 2019 Feb 21.

PMID:
30792243
6.

Precision Medicine for Aortic Stenosis: The Future of Cardiology Today.

Chandrashekhar YS, Johnson KW.

JACC Cardiovasc Imaging. 2019 Feb;12(2):249-251. doi: 10.1016/j.jcmg.2018.12.005. No abstract available.

PMID:
30732720
7.

Prevalence, Presentation, and Associated Conditions of Patients With Fibromuscular Dysplasia.

Krittanawong C, Kumar A, Johnson KW, Kaplin S, Virk HUH, Wang Z, Bhatt DL.

Am J Cardiol. 2019 Apr 1;123(7):1169-1172. doi: 10.1016/j.amjcard.2018.12.045. Epub 2019 Jan 10.

PMID:
30678834
8.

Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.

Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, Li L, Dudley JT, Johnson KW, Shervey MM, Xu H, Wu Y, Natrajan K, Hripcsak G, Jin P, Van Zandt M, Reckard A, Reich CG, Weaver J, Schuemie MJ, Ryan PB, Callahan A, Shah NH.

JAMA Netw Open. 2018 Aug 3;1(4):e181755. doi: 10.1001/jamanetworkopen.2018.1755.

9.

Conditions and Factors Associated With Spontaneous Coronary Artery Dissection (from a National Population-Based Cohort Study).

Krittanawong C, Kumar A, Johnson KW, Luo Y, Yue B, Wang Z, Bhatt DL.

Am J Cardiol. 2019 Jan 15;123(2):249-253. doi: 10.1016/j.amjcard.2018.10.012. Epub 2018 Oct 30.

PMID:
30477805
10.

Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining.

Shameer K, Perez-Rodriguez MM, Bachar R, Li L, Johnson A, Johnson KW, Glicksberg BS, Smith MR, Readhead B, Scarpa J, Jebakaran J, Kovatch P, Lim S, Goodman W, Reich DL, Kasarskis A, Tatonetti NP, Dudley JT.

BMC Med Inform Decis Mak. 2018 Sep 14;18(Suppl 3):79. doi: 10.1186/s12911-018-0653-3.

11.

Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, Min J, Torii S, Poojary P, Anand SS, Bax JJ, Yusuf S, Virmani R, Narula J.

J Am Coll Cardiol. 2018 Oct 30;72(18):2152-2163. doi: 10.1016/j.jacc.2018.08.002. Epub 2018 Aug 27.

PMID:
30166084
12.

Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis.

Ali M, Chang BA, Johnson KW, Morris SK.

Vaccine. 2018 Sep 18;36(39):5846-5857. doi: 10.1016/j.vaccine.2018.07.037. Epub 2018 Aug 23.

PMID:
30145101
13.

The whole is greater than the sum of its parts: combining classical statistical and machine intelligence methods in medicine.

Shameer K, Johnson KW, Glicksberg BS, Dudley JT, Sengupta PP.

Heart. 2018 Jul;104(14):1228. doi: 10.1136/heartjnl-2018-313377. No abstract available.

PMID:
29945951
14.
15.

A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Artery Disease.

Shameer K, Dow G, Glicksberg BS, Johnson KW, Ze Y, Tomlinson MS, Readhead B, Dudley JT, Kullo IJ.

AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:108-117. eCollection 2018.

16.

Artificial Intelligence in Cardiology.

Johnson KW, Torres Soto J, Glicksberg BS, Shameer K, Miotto R, Ali M, Ashley E, Dudley JT.

J Am Coll Cardiol. 2018 Jun 12;71(23):2668-2679. doi: 10.1016/j.jacc.2018.03.521. Review.

17.

The next generation of precision medicine: observational studies, electronic health records, biobanks and continuous monitoring.

Glicksberg BS, Johnson KW, Dudley JT.

Hum Mol Genet. 2018 May 1;27(R1):R56-R62. doi: 10.1093/hmg/ddy114. Review.

PMID:
29659828
18.

Machine learning in cardiovascular medicine: are we there yet?

Shameer K, Johnson KW, Glicksberg BS, Dudley JT, Sengupta PP.

Heart. 2018 Jul;104(14):1156-1164. doi: 10.1136/heartjnl-2017-311198. Epub 2018 Jan 19. Review.

PMID:
29352006
19.

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

Skljarevski V, Oakes TM, Zhang Q, Ferguson MB, Martinez J, Camporeale A, Johnson KW, Shan Q, Carter J, Schacht A, Goadsby PJ, Dodick DW.

JAMA Neurol. 2018 Feb 1;75(2):187-193. doi: 10.1001/jamaneurol.2017.3859. Erratum in: JAMA Neurol. 2018 Feb 1;75(2):260.

20.

Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.

Johnson KW, Glicksberg BS, Hodos RA, Shameer K, Dudley JT.

Pac Symp Biocomput. 2018;23:180-191.

21.

Automated disease cohort selection using word embeddings from Electronic Health Records.

Glicksberg BS, Miotto R, Johnson KW, Shameer K, Li L, Chen R, Dudley JT.

Pac Symp Biocomput. 2018;23:145-156.

22.

Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).

Okragly AJ, Morin SM, DeRosa D, Martin AP, Johnson KW, Johnson MP, Benschop RJ.

Cephalalgia. 2018 Aug;38(9):1564-1574. doi: 10.1177/0333102417740563. Epub 2017 Nov 5.

PMID:
29103295
23.

Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.

Wagman AS, Boyce RS, Brown SP, Fang E, Goff D, Jansen JM, Le VP, Levine BH, Ng SC, Ni ZJ, Nuss JM, Pfister KB, Ramurthy S, Renhowe PA, Ring DB, Shu W, Subramanian S, Zhou XA, Shafer CM, Harrison SD, Johnson KW, Bussiere DE.

J Med Chem. 2017 Oct 26;60(20):8482-8514. doi: 10.1021/acs.jmedchem.7b00922. Epub 2017 Oct 10.

PMID:
29016121
24.

Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes.

Chamaria S, Johnson KW, Vengrenyuk Y, Baber U, Shameer K, Divaraniya AA, Glicksberg BS, Li L, Bhatheja S, Moreno P, Maehara A, Mehran R, Dudley JT, Narula J, Sharma SK, Kini AS.

Sci Rep. 2017 Aug 1;7(1):7001. doi: 10.1038/s41598-017-07029-7.

25.

Sodium channel subtypes are differentially localized to pre- and post-synaptic sites in rat hippocampus.

Johnson KW, Herold KF, Milner TA, Hemmings HC Jr, Platholi J.

J Comp Neurol. 2017 Nov 1;525(16):3563-3578. doi: 10.1002/cne.24291. Epub 2017 Aug 11.

26.

Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.

Cooper ZD, Johnson KW, Vosburg SK, Sullivan MA, Manubay J, Martinez D, Jones JD, Saccone PA, Comer SD.

Drug Alcohol Depend. 2017 Sep 1;178:340-347. doi: 10.1016/j.drugalcdep.2017.04.029. Epub 2017 Jun 17.

PMID:
28688296
27.

Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine.

Johnson KW, Shameer K, Glicksberg BS, Readhead B, Sengupta PP, Björkegren JLM, Kovacic JC, Dudley JT.

JACC Basic Transl Sci. 2017 Jun 26;2(3):311-327. doi: 10.1016/j.jacbts.2016.11.010. eCollection 2017 Jun. Review.

28.

Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers.

Johnson KW, Neale A, Gordon A, Roessig J, Bezwada P, Vukelich S, Goldfine I, Rubin P.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):3021-3028. doi: 10.1210/jc.2017-00822.

PMID:
28605468
29.

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence.

Metz VE, Jones JD, Manubay J, Sullivan MA, Mogali S, Segoshi A, Madera G, Johnson KW, Comer SD.

Neuropsychopharmacology. 2017 Aug;42(9):1825-1832. doi: 10.1038/npp.2017.70. Epub 2017 Apr 10.

30.

CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.

Bohn KJ, Li B, Huang X, Mason BN, Wattiez AS, Kuburas A, Walker CS, Yang P, Yu J, Heinz BA, Johnson KW, Russo AF.

Br J Pharmacol. 2017 Jun;174(12):1826-1840. doi: 10.1111/bph.13783. Epub 2017 Apr 22.

31.

The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.

Iyengar S, Ossipov MH, Johnson KW.

Pain. 2017 Apr;158(4):543-559. doi: 10.1097/j.pain.0000000000000831. Review.

32.

Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.

Shameer K, Glicksberg BS, Hodos R, Johnson KW, Badgeley MA, Readhead B, Tomlinson MS, O'Connor T, Miotto R, Kidd BA, Chen R, Ma'ayan A, Dudley JT.

Brief Bioinform. 2018 Jul 20;19(4):656-678. doi: 10.1093/bib/bbw136.

33.

Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.

Kini AS, Vengrenyuk Y, Shameer K, Maehara A, Purushothaman M, Yoshimura T, Matsumura M, Aquino M, Haider N, Johnson KW, Readhead B, Kidd BA, Feig JE, Krishnan P, Sweeny J, Milind M, Moreno P, Mehran R, Kovacic JC, Baber U, Dudley JT, Narula J, Sharma S.

J Am Coll Cardiol. 2017 Feb 14;69(6):628-640. doi: 10.1016/j.jacc.2016.10.029. Epub 2016 Oct 29.

34.

Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.

Blanco MJ, Benesh DR, Knobelsdorf JA, Khilevich A, Cortez GS, Mokube F, Aicher TD, Groendyke TM, Marmsater FP, Tang TP, Johnson KW, Clemens-Smith A, Muhlhauser MA, Swanson S, Catlow J, Emkey R, Johnson MP, Schkeryantz JM.

Bioorg Med Chem Lett. 2017 Jan 15;27(2):323-328. doi: 10.1016/j.bmcl.2016.11.049. Epub 2016 Nov 18.

PMID:
27908761
35.

PREDICTIVE MODELING OF HOSPITAL READMISSION RATES USING ELECTRONIC MEDICAL RECORD-WIDE MACHINE LEARNING: A CASE-STUDY USING MOUNT SINAI HEART FAILURE COHORT.

Shameer K, Johnson KW, Yahi A, Miotto R, Li LI, Ricks D, Jebakaran J, Kovatch P, Sengupta PP, Gelijns S, Moskovitz A, Darrow B, David DL, Kasarskis A, Tatonetti NP, Pinney S, Dudley JT.

Pac Symp Biocomput. 2017;22:276-287. doi: 10.1142/9789813207813_0027.

36.

Medical student preparedness for an era of personalized medicine: findings from one US medical school.

Eden C, Johnson KW, Gottesman O, Bottinger EP, Abul-Husn NS.

Per Med. 2016 Mar;13(2):129-141.

37.

Pharmacological Modulation of GluK1 and GluK2 by NETO1, NETO2, and PSD95.

Li B, Rex E, Wang H, Qian Y, Ogden AM, Bleakman D, Johnson KW.

Assay Drug Dev Technol. 2016 Mar;14(2):131-43. doi: 10.1089/adt.2015.689.

PMID:
26991362
38.

The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers.

Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, Comer SD.

Addict Biol. 2016 Jul;21(4):895-903. doi: 10.1111/adb.12261. Epub 2015 May 14.

39.

A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation.

Hoehlig K, Johnson KW, Pryazhnikov E, Maasch C, Clemens-Smith A, Purschke WG, Vauléon S, Buchner K, Jarosch F, Khiroug L, Vater A, Klussmann S.

Br J Pharmacol. 2015 Jun;172(12):3086-98. doi: 10.1111/bph.13110. Epub 2015 Mar 27.

40.

Factors associated with variations in hospital expenditures for acute heart failure in the United States.

Ziaeian B, Sharma PP, Yu TC, Johnson KW, Fonarow GC.

Am Heart J. 2015 Feb;169(2):282-289.e15. doi: 10.1016/j.ahj.2014.11.007. Epub 2014 Nov 15.

41.

Transient and persistent worsening renal function during hospitalization for acute heart failure.

Krishnamoorthy A, Greiner MA, Sharma PP, DeVore AD, Johnson KW, Fonarow GC, Curtis LH, Hernandez AF.

Am Heart J. 2014 Dec;168(6):891-900. doi: 10.1016/j.ahj.2014.08.016. Epub 2014 Sep 16.

PMID:
25458653
42.

Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.

Mentz RJ, Mi X, Sharma PP, Qualls LG, DeVore AD, Johnson KW, Fonarow GC, Curtis LH, Hernandez AF.

Am J Cardiol. 2015 Jan 1;115(1):75-81. doi: 10.1016/j.amjcard.2014.09.048. Epub 2014 Oct 15.

43.

Application of the PRECEDE-PROCEED Planning Model in Designing an Oral Health Strategy.

Binkley CJ, Johnson KW.

J Theory Pract Dent Public Health. 2013 Nov;1(3). pii: http://www.sharmilachatterjee.com/ojs-2.3.8/index.php/JTPDPH/article/view/89.

44.

Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae.

Grace PM, Ramos KM, Rodgers KM, Wang X, Hutchinson MR, Lewis MT, Morgan KN, Kroll JL, Taylor FR, Strand KA, Zhang Y, Berkelhammer D, Huey MG, Greene LI, Cochran TA, Yin H, Barth DS, Johnson KW, Rice KC, Maier SF, Watkins LR.

Neuroscience. 2014 Nov 7;280:299-317. doi: 10.1016/j.neuroscience.2014.09.020. Epub 2014 Sep 18.

45.

Improving the oral health of residents with intellectual and developmental disabilities: an oral health strategy and pilot study.

Binkley CJ, Johnson KW, Abadi M, Thompson K, Shamblen SR, Young L, Zaksek B.

Eval Program Plann. 2014 Dec;47:54-63. doi: 10.1016/j.evalprogplan.2014.07.003. Epub 2014 Jul 27.

46.

Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes.

Abadi MH, Shamblen SR, Courser M, Johnson KW, Thompson K, Young L, Browne T.

Ethn Health. 2015;20(5):453-73. doi: 10.1080/13557858.2014.921898. Epub 2014 Jun 12.

PMID:
24920072
47.

Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.

Dreyfus N, Myers JK, Badescu VO, de Frutos O, de la Puente ML, Ding C, Filla SA, Fynboe K, Gernert DL, Heinz BA, Hemrick-Luecke SK, Johnson KW, Johnson MP, López P, Love PL, Martin LJ, Masquelin T, McCoy MJ, Mendiola J, Morrow D, Muhlhauser M, Pascual G, Perun TJ, Pfeifer LA, Phebus LA, Richards SJ, Rincón JA, Seest EP, Shah J, Shaojuan J, Simmons RM, Stephenson GA, Tromiczak EG, Thompson LK, Walter MW, Weber WW, Zarrinmayeh H, Thomas CE, Joshi E, Iyengar S, Johansson AM.

ACS Med Chem Lett. 2013 May 7;4(6):560-4. doi: 10.1021/ml400049p. eCollection 2013 Jun 13.

48.

Hazmat update.

Johnson KW, Schnepp R.

JEMS. 2014 Mar;39(3):42-5.

PMID:
24724334
49.

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain.

Benschop RJ, Collins EC, Darling RJ, Allan BW, Leung D, Conner EM, Nelson J, Gaynor B, Xu J, Wang XF, Lynch RA, Li B, McCarty D, Nisenbaum ES, Oskins JL, Lin C, Johnson KW, Chambers MG.

Osteoarthritis Cartilage. 2014 Apr;22(4):578-85. doi: 10.1016/j.joca.2014.01.009. Epub 2014 Feb 6. Erratum in: Osteoarthritis Cartilage. 2014 Nov;22(11):1951. Nisenbaum, E S [added].

50.

Southern Appalachian peatlands support high archaeal diversity.

Hawkins AN, Johnson KW, Bräuer SL.

Microb Ecol. 2014 Apr;67(3):587-602. doi: 10.1007/s00248-013-0352-7. Epub 2014 Jan 14.

PMID:
24419541

Supplemental Content

Loading ...
Support Center